喘中可治疗的特征和住院情况:并发症难题
Vanessa M McDonald1, Peter G Gibson1
1College of Health, Medicine and Wellbeing, University of Newcastle, and Asthma and Breathing Program, Hunter Medical Research Institute, New Lambton, Australia.
ERJ open research
|February 25, 2026
概括
可治疗的并发症显著增加了喘住院的风险. 针对这些疾病提供了一种可行的治疗策略,以改善患者的治疗结果并减少住院患者.
科学领域:
- 肺部医学 肺部医学
- 临床研究 临床研究
- 流行病学 流行病学
背景情况:
- 喘是一种慢性呼吸道疾病,影响全球数百万人.
- 住院治疗仍然是严重喘恶化的一个重要问题.
- 伴随性疾病在喘患者中很常见,可能会影响疾病的严重程度.
研究的目的:
- 调查并发症可治疗特征与喘住院风险之间的关联.
- 为了确定是否针对这些特征可以减轻住院率.
主要方法:
- 电子健康记录的回顾性分析.
- 在喘患者中识别常见的并发症.
- 统计建模以评估伴随性疾病对住院和治疗反应的影响.
主要成果:
- 发现特定可治疗的并发症显著增加了喘住院的风险.
- 接受针对这些并发症的向治疗的患者的住院率降低.
- 多种并发症的存在加大了风险.
结论:
- 可治疗的并发症是喘住院的关键风险因素.
- 针对这些并发性疾病的干预措施有效地减少了与喘相关的住院治疗.
- 针对伴随性疾病的个性化治疗策略对于喘管理至关重要.
相关概念视频
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942


